Gemspring Capital invests in Residence, a global network of creative companies, to fuel growth and empower creative potential.

Elliott Davis receives investment from Flexpoint Ford, names John Otten as new CEO effective July 1, 2025, as part of strategic growth plan.

EQT Life Sciences co-leads $135M Series B for SpliceBio, funding clinical trials for Stargardt disease gene therapy and pipeline expansion.

Nordic Capital invests in Minerva Imaging to accelerate growth in radiopharmaceutical space, aiming for global market leadership.

EQT Life Sciences leads $80M Series A funding for Mosanna Therapeutics to advance a nasal spray therapy for obstructive sleep apnea.

Black Dragon Capital™ and Origence form strategic partnership to develop fintech solutions for credit unions.

GTCR forms Maris Investments with maritime industry veteran Manish Singh to acquire and build companies in maritime technology sector.

H.I.G. Capital acquires ITH Group, a UK provider of aseptic pharmaceutical compounding services, in partnership with its founders.

Private markets face a critical inflection point with rating controversies exposing hidden risks, 30,000 unsold PE companies creating exit backlogs, and industry leaders warning the sector has "lost its way." Yet opportunities emerge through European expansion, AI infrastructure needs, and wealth democratization as regulators push to eliminate accredited investor barriers—reshaping the industry's future.RetryClaude can make mistakes. Please double-check responses.

Private markets titans gathered at SuperReturn 2025 in Berlin delivered a sobering assessment of an industry grappling with what Julian Salisbury of Sixth Street Partners called "bad vintage assets" that have created systemic "indigestion" throughout the market.

Spencer Trask & Co.'s early investment in SeedInvest pays off as Circle, which acquired SeedInvest in 2019, goes public on NYSE.

José Luis González Pastor, Managing Director at Neuberger Berman covering private markets and co-investments, spoke on that Fund Shack podcast from the SuperReturn Conference in Berlin about the current state of private equity in 2025. González Pastor identifies a significant liquidity crunch gripping private markets, with deal-making activity stalling due to political and macroeconomic uncertainty despite initial optimism for 2025.

H.I.G. Capital's portfolio company Highridge Medical sells its EBI Bone Healing Division to Avista Healthcare Partners.

H.I.G. Capital's portfolio company Highridge Medical completes sale of EBI Bone Healing Division to Avista Healthcare Partners.

EQT sells shares in Galderma Group AG for CHF 1.86 billion, receiving CHF 494 million in gross proceeds from the transaction.

The three largest players in private equity—Blackstone, Apollo, and KKR—are pursuing dramatically different business models after decades of similar strategies, according to the Financial Times. While all three firms dominated the industry using comparable approaches through 2020, the post-pandemic era has revealed sharp strategic divergences that could determine their resilience during market downturns.

Thoma Bravo raises $34.4 billion across three funds, demonstrating strong investor support for its software investment strategy.

CenterGate Capital sells Mid-State Industrial Maintenance to ONCAP, marking a successful exit for the Austin-based private equity firm.

Private equity dealmaking lost significant steam in the second quarter of 2025 after tariff policy announcements triggered widespread market volatility. According to Bain & Company's Private Equity Midyear Report 2025, deal values in April dropped 24% below Q1 monthly averages while deal counts fell 22%, with the IPO market essentially shutting down as companies like Klarna paused public offering plans amid trade uncertainty.

Ara Partners' 2024 report showcases progress in emissions reduction and waste management across its industrial economy investments.